| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And CEO | President &CEO | Chief Operating Officer
1 company
Campbell Bradley L is a President And CEO at AMICUS THERAPEUTICS, INC.. Recent SEC Form 4 filings include 0 buys and 6 sells.
Estimated insider holdings value: $14.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 9, 2020 | FOLD Amicus Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 2,500 | $10.01 | $25,025.00 | -0.7% | |
| Jan 2, 2020 | FOLD Amicus Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 22,127 | $9.58 | $211,889.21 | -3.0% | |
| Jan 22, 2019 | FOLD Amicus Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 36,000 | $11.81 | $425,134.80 | -13.1% | |
| Jan 22, 2018 | FOLD Amicus Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 32,500 | $15.92 | $517,370.75 | -17.4% | |
| Mar 2, 2017 | FOLD Amicus Therapeutics, Inc. | Chief Operating Officer | Sell | 49,050 | $8.00 | $392,400.00 | -27.8% |